Repurposed cancer treatments could be potential Alzheimer's drugs

A pair of existing cancer drugs, one FDA-approved and another still experimental, showed promise for being repurposed as therapies in ...

Their findings show an experimental drug for liver cancer and Dasatinib, approved for chronic myeloid leukemia, act upon some of these ...

Cancer drug could treat early-stage Alzheimer's disease, study shows

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, ...

New hope for Alzheimer's patients? Cancer drug shows 'high potential'

A type of drug being developed to combat cancer could be repurposed to treat the early stages of neurodegenerative diseases such as ...

Existing cancer drugs could become new Alzheimer's treatments

An experimental drug for liver cancer and Dasatinib, approved for chronic myeloid leukaemia, may be repurposed to treat Alzheimer's disease.

Cancer drug could treat early-stage Alzheimer's disease, study shows

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, ...

Cancer Drug May Reverse Alzheimer's Disease - Newsweek

Existing cancer drugs have shown promise as a future treatment for Alzheimer's disease, new research has found.

Three promising drugs for treating Alzheimer's disease bring fresh ...

For the first time, new drugs have been approved in the UK that can slow down memory and thinking decline in early Alzheimer's disease.

Cell Engineering Team Links Cancer Drug to Potential Therapy for ...

In the case of Alzheimer's disease, Tau proteins detach from their scaffolding structure, become misfolded, clump together and accumulate in ...

Advances in cancer neuroscience and drug discovery could benefit ...

Unparalleled drug discovery and development expertise · Alzheimer's disease and age-related diseases could affect future cancer research and care.

Alzheimer's Mice Have Memory and Brain Function "Rescued" by ...

“We're hopeful that IDO1 inhibitors developed for cancer could be repurposed for treatment of AD,” Andreasson stressed. Added co-author ...

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

NIH study says repurposed cancer therapies beneficial for Alzheimer's

NIA scientists at NIH have found that present and developing therapies for cancer could potentially be repurposed to treat Alzheimer's ...

Alzheimer's treatments: What's on the horizon? - Mayo Clinic

A medicine initially developed as a possible cancer treatment — saracatinib — is now being tested in Alzheimer's disease. In mice, saracatinib turned off a ...

Researchers call for a major rethink of how Alzheimer's treatments ...

In January 2023, the US Food and Drug Administration (FDA) approved lecanemab — an antibody medication that decreases β-amyloid protein build-up ...

New Treatment Reverses Alzheimer's Disease Signs - Penn Medicine

As a potential Alzheimer's treatment, PBA has the advantage that it can cross easily from the bloodstream into the brain and is already ...

More Evidence in Quest to Repurpose Cancer Drugs for Alzheimer's ...

More Evidence in Quest to Repurpose Cancer Drugs for Alzheimer's Disease ... TORONTO (July 27, 2016) – An FDA approved drug to treat renal cell carcinoma ...

Alzheimer's Drug Development Pipeline: Positive Results, New ...

Alzheimer's treatment studies offer hope as UNLV expert predicts new potential drugs, biomarkers will yield critical insight for future development.

UW study examines potential treatment for Alzheimer's disease

Researchers are investigating whether the drug leuprolide, which is approved for prostate cancer in men, can be used to treat symptoms of ...

Recent advances in Alzheimer's disease: mechanisms, clinical trials ...

However, recent approvals of aducanumab (1) and lecanemab (2) by the Food and Drug Administration (FDA) present the potential in disrease- ...